Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.

Author: HouN, LiX, LiuH, LyuJ, SongL, XiaZ

Paper Details 
Original Abstract of the Article :
Rheumatoid arthritis (RA) is a potentially destructive disease that may have a profound impact on patients' function and quality of life. RA therapy is still a challenge for rheumatologists; however, new antirheumatic drugs may be a treatment option for disease-modifying antirheumatic drug (DMARD)-e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00393-015-1641-y

データ提供:米国国立医学図書館(NLM)

Iguratimod: A New Ally in the Battle Against Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease that can significantly impact quality of life. This study explores the potential of iguratimod, a novel antirheumatic drug, as a treatment option for patients with active RA. The authors investigated the therapeutic effects of iguratimod in combination with methotrexate, a commonly used RA medication.

A New Weapon in the Arsenal: Iguratimod and Rheumatoid Arthritis

The research suggests that iguratimod, when used in combination with methotrexate, may offer promising therapeutic benefits for patients with active RA. This finding holds potential for improving treatment outcomes for individuals with RA who have not responded well to conventional therapies. Further research is needed to fully assess the efficacy and safety of iguratimod in this population.

Finding New Hope: Treatment Options for Rheumatoid Arthritis

This research offers hope for individuals struggling with rheumatoid arthritis. The development of new antirheumatic drugs like iguratimod provides a potential new pathway for managing this debilitating disease. Further research and clinical trials are needed to fully understand the role of iguratimod in RA treatment and its potential to improve patient outcomes.

Dr.Camel's Conclusion

This research is a reminder that the desert of rheumatoid arthritis can be a challenging landscape to navigate. The development of iguratimod, a new antirheumatic drug, offers a potential oasis of hope for patients seeking effective treatment options. It's a reminder that the search for new solutions continues in the field of rheumatology, offering potential for improved outcomes for individuals living with RA.

Date :
  1. Date Completed 2017-05-17
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

26508503

DOI: Digital Object Identifier

10.1007/s00393-015-1641-y

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.